Vascular & Aortic Sharon Greyling Vascular & Aortic Sharon Greyling

Europe & US – 41 EVAR Physicians: Message Testing at Congress

Testing Aortic Messaging at Congress: 41 Interviews in Germany and Miami

Recruiting and researching at congresses provides the best chance to quickly and efficiently capture a true cross-section of physicians: ideal for Europe.

A manufacturer needed to finalize launch messaging for a new abdominal aortic stent-graft, as well as campaign messaging for its established device and broader aortic portfolio. The same interviews also explored…

 

Read More
Cardiology & Heart Failure, Vascular & Aortic Sharon Greyling Cardiology & Heart Failure, Vascular & Aortic Sharon Greyling

US – 12 TAVR and TEVAR Specialists: Embolic Protection Concept Test

Same Device, Different Hands: Testing Embolic Protection in TAVR and TEVAR

A single-device concept was being considered for two very different procedures, each carried out by a different specialist. To get useful feedback, the recruit had to cover both.

A manufacturer was developing a single-vessel cerebral embolic protection device and wanted to understand where it might fit during transcatheter aortic valve replacement (TAVR) and…

Read More
Vascular & Aortic Sharon Greyling Vascular & Aortic Sharon Greyling

US – 15 EVAR Physicians: AAA Case Planning Interviews

Ask About the Last Case: Recruiting EVAR Physicians for Real, Recent Experience

Ask a physician how they usually plan a case and you get the textbook answer. Ask them to walk you through their last one and you get what actually happened.

A manufacturer wanted to map how US physicians plan standard abdominal aortic aneurysm repair with EVAR: from requesting CT images to measurements…

Read More
Vascular & Aortic Sharon Greyling Vascular & Aortic Sharon Greyling

Europe & US – 35 Physicians: In-Person Aortic Stent-Graft Interviews

Testing demand for a next-generation aortic stent-graft alongside its predecessor in London, Chicago, and New York

Some questions can't be answered from a screen. Physicians need to see and handle the device.

A manufacturer planned to launch a next-generation aortic stent-graft while keeping its established version on the market. It needed to know whether physicians saw value in having both.

Each one-hour structured interview…

 

Read More
Vascular & Aortic Sharon Greyling Vascular & Aortic Sharon Greyling

China, Europe, US & Japan – 345 Aortic Specialists: Market Sizing Survey

Sizing the Visceral Aortic Market: 345 Specialists, Four Regions, One Survey

Sizing a market requires a sample with reach, and this one exceeded the target in every region.

A manufacturer developing a device for aneurysms near or involving the renal arteries wanted to know whether the visceral segment is worth investing in and how to segment it.

The answer called for a quantitative read…

Read More
Vascular & Aortic Sharon Greyling Vascular & Aortic Sharon Greyling

US, Germany & UK – 24 Large-Bore Specialists: Sheath and Closure Concepts

24 Physicians, Three Markets, One Clear Read on Large-Bore Concepts

A balanced, in-person recruit made cross-market comparison simple.

A manufacturer wanted to test new concepts for its large-bore sheath and gauge reactions to two large-bore closure device concepts. It also wanted to validate the clinical pain points behind these ideas.

Large-bore access spans aortic, peripheral and structural heart work, so the recruit included several…

 

Read More
Vascular & Aortic, Cardiology & Heart Failure Sharon Greyling Vascular & Aortic, Cardiology & Heart Failure Sharon Greyling

US, Germany & UK – 29 Aortic and Structural Specialists: Expandable Sheath Test

our Specialties, Two Continents: Blinded, In-Person Testing of an Expandable Sheath Concept

Large-bore access is a problem in both aortic and structural heart procedures, so the sample had to cover both.

A manufacturer sought reactions to an expandable sheath concept, as well as physicians' experiences with large-profile devices and existing expandable sheaths.

Because large-bore access matters in both aortic and structural heart procedures, the…

 

Read More
Vascular & Aortic Sharon Greyling Vascular & Aortic Sharon Greyling

US & Europe – 45 Physicians and Buyers: Brand Positioning Research

Recruiting for Ideas: Finding Respondents Who Can Talk Brand Positioning

A medical device business wanted to test its brand position: what it could credibly own in the minds of physicians and hospital buyers. That called for respondents who could step back from individual products and discuss companies, markets, and marketing ideas.

So the recruit was deliberately selective. Physicians were drawn from surgeons we had…

Read More
Vascular & Aortic Sharon Greyling Vascular & Aortic Sharon Greyling

US & Europe – 8 Stent Graft Users: Brand Positioning Feedback

The Right Mix Over Big Numbers: Early Feedback on a Brand Position

Early-stage positioning doesn't need a large sample. It needs the right specialists quickly.

A manufacturer was developing a new brand position for a family of covered stent grafts. It wanted early feedback on the brand story, positioning statement, tagline, and pillars.

This was the second round of an iterative program. The screening…

 

Read More
Vascular & Aortic Sharon Greyling Vascular & Aortic Sharon Greyling

US & Europe – 31 Vascular Specialists: Accessory Concepts Tested In Person

31 Vascular Specialists, Three Venues: How In-Person Fieldwork Tested Three Procedural Accessory Concepts

Hands-on concepts demand in-person interviews, so we built the recruit around where vascular specialists already gather: a research facility and two major congresses.

A manufacturer wanted feedback on three procedural accessory concepts: a steerable sheath, a large-bore closure patch and a thrombectomy docking device.

For each, it wanted to understand current…

Read More
Vascular & Aortic Sharon Greyling Vascular & Aortic Sharon Greyling

US & Europe – 27 Complex Aortic Specialists: Fieldwork at VEITH

27 Complex Aortic Specialists in Five Days: Fieldwork at VEITH

Complex aneurysm repair is a small, specialized field, and many of its key physicians gather in one place each year: the VEITH Symposium in New York. So, when a client needed to hear from them, we went to where they already were.

A device company wanted to understand how physicians choose between off-the-shelf fenestrated…

Read More
Vascular & Aortic Sharon Greyling Vascular & Aortic Sharon Greyling

US & Europe – 24 Vascular Specialists: Stent Graft Interviews at VEITH

Will a Next-Generation Stent Graft Change Practice? Asking High and Low Users at VEITH

By interviewing both heavy and light users of the current device, we estimated how far a next-generation version could shift treatment choices.

A manufacturer wanted to validate the scope of a next-generation balloon-expandable covered stent graft and judge whether it would shift treatment choices in aortoiliac occlusive disease and complex…

Read More
Nephrology & Dialysis Access, Vascular & Aortic Sharon Greyling Nephrology & Dialysis Access, Vascular & Aortic Sharon Greyling

US – 24 Vascular Surgeons: Dialysis Access Messaging

Two Rounds, 24 Surgeons: Building Dialysis Access Messaging from the Inside Out

Build the concepts with the surgeons who know the products best, test them on everyone else, and stop once the findings settle.

A manufacturer wanted positioning and messaging for its portfolio of three dialysis access devices, presented as a single solution set.

The research used an iterative design with two rounds of…

 

 

Read More
Vascular & Aortic Sharon Greyling Vascular & Aortic Sharon Greyling

US – 40 PAD Specialists: Intravascular Lithotripsy Research

Getting the Mix Right: Recruiting 40 PAD Specialists Who Reflect the US IVL Market

Why balancing vascular surgeons, interventional radiologists, and interventional cardiologists shaped the client’s learning.

A device company wanted to understand the opportunity in intravascular lithotripsy (IVL) for peripheral arterial disease (PAD): how physicians use it, how they view current suppliers, and what a stent graft manufacturer offering IVL might mean for...

 

Read More
Vascular & Aortic Sharon Greyling Vascular & Aortic Sharon Greyling

Europe & US – 21 Aortic Physicians: Message Testing in Europe

Lost in Translation: Testing Aortic Messaging With Non-Native English Speakers

Most of the world's physicians read marketing in their second language. If a message only works for native speakers, it isn't working.

A manufacturer wanted to finalize messaging for a branch stent-graft. Foundational testing had already taken place at congress in the US. This round moved to Europe.

Interviews were held at the congress…

 

Read More
Vascular & Aortic Sharon Greyling Vascular & Aortic Sharon Greyling

US & Europe – 30 Vascular Physicians: Stent Graft Message Testing

From Congress Floor to Zoom: Recruiting 30 Vascular Physicians for Message Testing

In-person interviews shaped the language; remote follow-ups validated it.

A manufacturer preparing a lower-profile version of a balloon-expandable covered stent graft wanted to know which words and headlines would most motivate physicians treating aortoiliac occlusive disease.

The target sample was physicians who see at least 40 patients a year with aortoiliac or…

Read More
Vascular & Aortic Sharon Greyling Vascular & Aortic Sharon Greyling

Five Markets – 14 Aortic Surgeons: Terminology and Naming Check

What Do Surgeons Call It? A 20-Minute, Five-Market Terminology Check

Before a launch, getting the name right matters. The question was simple: what do surgeons call it?

Ahead of a launch, a manufacturer wanted to confirm the language surgeons use for complex disease involving the visceral segment.

Each surgeon had to be actively performing endovascular aortic procedures and using the client's thoracic and abdominal…

Read More